Literature DB >> 33621803

Telomere length is associated with HIV infection, methamphetamine use, inflammation, and comorbid disease risk.

Sanjay R Mehta1, Jennifer E Iudicello2, Jue Lin3, Ronald J Ellis4, Erin Morgan2, Oluwakemi Okwuegbuna5, Debra Cookson2, Maile Karris5, Rowan Saloner2, Robert Heaton2, Igor Grant2, Scott Letendre5.   

Abstract

BACKGROUND: HIV infection and methamphetamine dependence (METH) are each associated with inflammation and premature aging, but their impact on biological aging is difficult to measure. Here we examined the impact of HIV and METH on leukocyte telomere lengths (LTL), and the correlations between LTL and other aging biomarkers.
METHODS: The study was a cross-sectional analysis of 161 individuals categorized by HIV and methamphetamine (METH) dependence status into four groups: HIV-METH- (n = 50), HIV-METH+ (n = 29), HIV + METH- (n = 40), and HIV + METH+ (n = 42). We analyzed the relationships of leukocyte telomere length (telomere to single copy gene [T/S] ratio) with demographic and clinical data as well as a panel of biomarkers of inflammation and endothelial activation measured in blood and cerebrospinal fluid (CSF).
RESULTS: HIV and METH were independently associated with shorter T/S ratio, even after adjusting for demographics and leukocyte count (R2 = 0·59, p < 0·0001). Higher plasma C-reactive protein (p = 0·0036) and CSF VCAM-1 (p = 0·0080) were also associated with shorter T/S ratio. A shorter T/S ratio was associated with higher risk for cardiovascular disease (p < 0·0001) and stroke (p < 0·0001), worse motor functioning (p = 0·037) and processing speed (p = 0·023), more depressive symptoms (p = 0·013), and higher CSF neurofilament-light (p = 0·003).
CONCLUSIONS: HIV and METH dependence were each associated with shorter telomeres. After adjusting for demographics, HIV, and METH, T/S ratio remained associated with aging-related outcomes including neurocognitive impairment, neurodegeneration, risks of cardiovascular disease and stroke. While not establishing causality, this study supports using the T/S ratio as a biomarker for estimating the impact of HIV and comorbidities on long-term health. Published by Elsevier B.V.

Entities:  

Keywords:  Aging; Cardiovascular; HIV; Methamphetamine; Telomeres

Mesh:

Substances:

Year:  2021        PMID: 33621803      PMCID: PMC8026664          DOI: 10.1016/j.drugalcdep.2021.108639

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  33 in total

Review 1.  Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection.

Authors:  Elizabeth H Blackburn; Elissa S Epel; Jue Lin
Journal:  Science       Date:  2015-12-04       Impact factor: 47.728

2.  Telomere Length and Frailty: The Helsinki Birth Cohort Study.

Authors:  Markus J Haapanen; Mia-Maria Perälä; Minna K Salonen; Maria A Guzzardi; Patricia Iozzo; Eero Kajantie; Taina Rantanen; Mika Simonen; Pertti Pohjolainen; Johan G Eriksson; Mikaela B von Bonsdorff
Journal:  J Am Med Dir Assoc       Date:  2018-06-28       Impact factor: 4.669

3.  Methamphetamine users show greater than normal age-related cortical gray matter loss.

Authors:  Helenna Nakama; Linda Chang; George Fein; Ryan Shimotsu; Caroline S Jiang; Thomas Ernst
Journal:  Addiction       Date:  2011-05-12       Impact factor: 6.526

Review 4.  The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Authors:  Bryan K Yamamoto; Jamie Raudensky
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-15       Impact factor: 4.147

Review 5.  Methamphetamine and cardiovascular pathology: a review of the evidence.

Authors:  Sharlene Kaye; Rebecca McKetin; Johan Duflou; Shane Darke
Journal:  Addiction       Date:  2007-06-12       Impact factor: 6.526

6.  Race/ethnicity and telomere length in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Ana V Diez Roux; Nalini Ranjit; Nancy S Jenny; Steven Shea; Mary Cushman; Annette Fitzpatrick; Teresa Seeman
Journal:  Aging Cell       Date:  2009-03-17       Impact factor: 9.304

7.  Leukocyte telomere length and renal cell carcinoma survival in two studies.

Authors:  Catherine L Callahan; Kendra Schwartz; Julie J Ruterbusch; Brian Shuch; Barry I Graubard; Qing Lan; Richard Cawthon; Andrea A Baccarelli; Wong-Ho Chow; Nathaniel Rothman; Jonathan N Hofmann; Mark P Purdue
Journal:  Br J Cancer       Date:  2017-07-25       Impact factor: 7.640

8.  Association between telomere length and complete blood count in US adults.

Authors:  Mohsen Mazidi; Peter Penson; Maciej Banach
Journal:  Arch Med Sci       Date:  2017-04-20       Impact factor: 3.318

9.  DNA methylation age of human tissues and cell types.

Authors:  Steve Horvath
Journal:  Genome Biol       Date:  2013       Impact factor: 13.583

Review 10.  Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis.

Authors:  Philip C Haycock; Emma E Heydon; Stephen Kaptoge; Adam S Butterworth; Alex Thompson; Peter Willeit
Journal:  BMJ       Date:  2014-07-08
View more
  4 in total

1.  Sexual Minority Stress and Cellular Aging in Methamphetamine-Using Sexual Minority Men With Treated HIV.

Authors:  Delaram Ghanooni; Adam W Carrico; Renessa Williams; Tiffany R Glynn; Judith T Moskowitz; Savita Pahwa; Suresh Pallikkuth; Margaret E Roach; Samantha Dilworth; Bradley E Aouizerat; Annesa Flentje
Journal:  Psychosom Med       Date:  2022-08-16       Impact factor: 3.864

2.  Mental Disorders Are Associated With Leukocytes Telomere Shortening Among People Who Inject Drugs.

Authors:  Mélusine Durand; Nicolas Nagot; Laurent Michel; Sao Mai Le; Huong Thi Duong; Roselyne Vallo; Amélie Vizeneux; Delphine Rapoud; Hoang Thi Giang; Catherine Quillet; Nham Thi Tuyet Thanh; Khuat Thi Hai Oanh; Vu Hai Vinh; Jonathan Feelemyer; Philippe Vande Perre; Khue Pham Minh; Didier Laureillard; Don Des Jarlais; Jean-Pierre Molès
Journal:  Front Psychiatry       Date:  2022-06-17       Impact factor: 5.435

Review 3.  Ageing and older people who use illicit opioids, cocaine or methamphetamine: a scoping review and literature map.

Authors:  Camille Zolopa; Stine B Høj; Nanor Minoyan; Julie Bruneau; Iuliia Makarenko; Sarah Larney
Journal:  Addiction       Date:  2022-02-10       Impact factor: 7.256

Review 4.  Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders.

Authors:  Nikolai Fattakhov; Silvia Torices; Michael Stangis; Minseon Park; Michal Toborek
Journal:  Viruses       Date:  2021-09-21       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.